Isosceles Pharmaceuticals

0 followers


Isosceles Pharmaceuticals is an preclinical stage biotech developing a perioperative acute pain product candidates using actives with an approved drug master file and an excellent safety profile.

Industries

Employees

1-10

Links

Org chart

Herbert Neuman
Chief Medical Officer
Deborah Mosca
Chief Strategy Officer
Robert B. Stein
Chief Medical Advisor & Director
Mark A. Mannebach
Regulatory Affairs Strategy

Board & advisors

Tim Wright
Executive Chairman
Mike A. Royal
Medical Advisor
Thomas L. Harrison
Strategic Advisor
Devin Bosch
Board Member
Kevin Fickle
Board Member
Michael Giuliani
Medical & Clinical Advisor